INTELLECTUAL PROPERTY
Genes Are Still Patentable, Federal Appeals Court Rules
An appellate court reinstated Myriad Genetics exclusive rights to research two cancer-linked genes, leaving others researching these genes out in the cold.
PATENT RIGHTS
Supreme Court Rules in Favor of Transnational Corp. over Stanford University in Patent Case
The Supreme Court’s answer to the question of who owns the products of federally funded research highlights tensions within academic-industrial relationships in research and development.
GENOMICS
Court Rules that DNA Is Information, Not Intellectual Property
A lawsuit argued that patents owned by Myriad Genetics on two genes connected to breast and ovarian cancer stunt genetic research and limit access to health care for women. The ruling said that genes can’t be patented.
Roundup: ACLU Sues Over Breast Cancer Gene Patents
The American Civil Liberties Union filed suit Tuesday against the U.S. Patent and Trademark Office, Myriad Genetics, and the University of Utah, arguing that patents for the BRCA1 and BRCA2 genes are invalid. Mutations in the two genes are responsible [...]
Get our Email Newsletter:
Connect:
What We Work On
Science, Innovation, and Competitiveness
Science Progress and American Progress's Doing What Works project teamed up to produce a set of policy proposals that the Obama administration and Congress can adopt to reinvest in the building blocks of American science, innovation, and economic competitiveness. Read the overview of the five reports.
What We Believe
Science Progress proceeds from the propositions that scientific inquiry is among the finest expressions of human excellence, that it is a crucial source of human flourishing, a critical engine of economic growth, and must be dedicated to the common good. Scientific inquiry entails global responsibilities. It should lead to a more equitable, safer, and healthier future for all of humankind.